Microneedling with tranexamic acid for red stretch marks
This trial tests a treatment for red stretch marks (striae rubra) using tiny needles to apply a medicine called tranexamic acid to the skin. It aims to see if this treatment is safe and effective in improving the appearance of stretch marks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have red or pink stretch marks that appear on both sides of your body in a similar pattern.
- You are not pregnant or breastfeeding.
- You do not have a history of keloids (raised scars) or hypertrophic scars.
- You do not have an active skin infection in the area to be treated.
- You have not used other stretch mark treatments in the last 3 months, and you are not taking blood thinners or certain steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining microneedling (tiny needles that stimulate skin repair) with a tretinoin cream (a vitamin A derivative) can improve the appearance of red or pink stretch marks. It is designed for adults with these early-stage stretch marks.
This study compares two treatments—pulsed dye laser and carboxytherapy—for red stretch marks (striae rubra) that are the same on both sides of the body. It aims to find which treatment works better with fewer side effects.
This trial tests a treatment called deep skin abrasion for stretch marks. It may help improve the appearance of stretch marks by gently sanding the top layers of skin.
This study tests whether combining oral tranexamic acid with a special skin needling treatment helps reduce melasma (dark facial patches). It is designed for women aged 18-50 who have melasma and are not pregnant or on certain medications.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
This trial tests tranexamic acid to see if it improves two types of long-lasting skin pigment problems (lichen planus pigmentosus and erythema dyschromicum perstans). You may be asked to stop other pigment treatments for about a month before starting, and you’ll be screened for clotting and pregnancy-related risks.
Hear when a new Striae Rubra trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.